A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab

Completed · Phase 1

Conditions studied: Migraine in Children, Migraine

In brief

The purpose of the study is to investigate how the body absorbs, distributes, and get rid of eptinezumab when given directly into a vein.

Key facts

Study ID: NCT04537429
Run by: H. Lundbeck A/S
People needed: 28
Starts: 2020-08-04
Expected to finish: 2023-08-21
Last updated by the study team: 2023-10-06

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

The patient has a diagnosis of migraine with or without aura according to international classification of headache disorders (ICHD)-3 (in the opinion of the investigator) for ≥6 months prior to the Screening Visit and has a frequency of migraine ≥4 migraine days per month for at least 3 months prior to the Screening Visit.

You may not qualify if…

The patient has been exposed to any monoclonal antibody treatment (including exposure in a study) <6 months prior to the Screening Visit.
Other in- and exclusion criteria may apply

Where it is running

New England Institute for Clinical Research — Stamford, Connecticut, United States
NW FL Clinical Research Group LLC — Gulf Breeze, Florida, United States
The Premiere Research Institute at Palm Beach Neurology — West Palm Beach, Florida, United States
College Park Family Care Center — Overland Park, Kansas, United States
Michigan Head Pain and Neurological Institute — Ann Arbor, Michigan, United States
Preferred Primary Care Physicians Inc. — Pittsburgh, Pennsylvania, United States
North Texas Institute of Neurology & Headache — Frisco, Texas, United States
Road Runner Research Ltd — San Antonio, Texas, United States
Wasatch Clinical Research — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.